Pharmacokinetics, safety and antiviral activity of fosamprenavir/ritonavir-containing regimens in HIV-infected children aged 4 weeks to 2 years-48-week study data (Q30652267)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacokinetics, safety and antiviral activity of fosamprenavir/ritonavir-containing regimens in HIV-infected children aged 4 weeks to 2 years-48-week study data |
scientific article |
Statements
1 reference
Pharmacokinetics, safety and antiviral activity of fosamprenavir/ritonavir-containing regimens in HIV-infected children aged 4 weeks to 2 years-48-week study data (English)
1 reference
Harmony P Garges
1 reference
Mark Cotton
1 reference
Haseena Cassim
1 reference
Noris Pavía-Ruz
1 reference
Teodora Perger
1 reference
Susan L Ford
1 reference
Mary Beth Wire
1 reference
Naomi Givens
1 reference
Lisa L Ross
1 reference
Yu Lou
1 reference
Jörg Sievers
1 reference
Katharine Cheng
1 reference
1 January 2014
1 reference
1 reference
57-62
1 reference
Identifiers
1 reference
1 reference
1 reference